SG HealthCare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Revenue	24,601	16,105	27,779	25,499
Other Revenue	-0	-	-0	-0
Revenue	24,601	16,105	27,779	25,499
Revenue Growth (YoY)	52.76%	-42.02%	8.94%	-
Cost of Revenue	17,517	10,968	20,687	19,344
Gross Profit	7,084	5,136	7,091	6,155
Selling, General & Admin	4,261	4,289	3,852	3,672
Research & Development	888.22	681.85	557.34	517.39
Amortization of Goodwill & Intangibles	-	1.62	1.46	1.45
Other Operating Expenses	5.59	4.07	5.93	8.74
Operating Expenses	5,617	5,809	4,844	4,396
Operating Income	1,467	-673.1	2,248	1,759
Interest Expense	-385.16	-483.91	-1,017	-1,509
Interest & Investment Income	146.91	135.66	122.96	56.79
Earnings From Equity Investments	-	-	-0.91	-1.15
Currency Exchange Gain (Loss)	-214.81	936.02	129.77	67.54
Other Non Operating Income (Expenses)	-10.04	-3,475	716.86	-641.05
EBT Excluding Unusual Items	1,004	-3,561	2,199	-267.75
Gain (Loss) on Sale of Investments	32.23	-10.27	-	-1.36
Gain (Loss) on Sale of Assets	-4.13	-71.42	-	1.53
Asset Writedown	5	-13	-84.13	-
Pretax Income	1,037	-3,655	2,115	-267.57
Income Tax Expense	102.26	-122.31	339.19	183.37
Earnings From Continuing Operations	935.05	-3,533	1,776	-450.94
Minority Interest in Earnings	0.55	-14.42	-9.22	-
Net Income	935.6	-3,547	1,767	-450.94
Net Income to Common	935.6	-3,547	1,767	-450.94
Shares Outstanding (Basic)	11	9	8	6
Shares Outstanding (Diluted)	11	9	8	6
Shares Change (YoY)	19.77%	18.98%	28.47%	-
EPS (Basic)	86.00	-386.00	228.74	-75.00
EPS (Diluted)	85.00	-386.00	228.74	-75.00
Free Cash Flow	-5,936	-2,936	-432.66	-1,946
Free Cash Flow Per Share	-539.27	-319.44	-56.01	-323.67
Gross Margin	28.80%	31.89%	25.53%	24.14%
Operating Margin	5.96%	-4.18%	8.09%	6.90%
Profit Margin	3.80%	-22.03%	6.36%	-1.77%
Free Cash Flow Margin	-24.13%	-18.23%	-1.56%	-7.63%
EBITDA	2,107	-303.9	2,552	2,055
EBITDA Margin	8.56%	-1.89%	9.19%	8.06%
D&A For EBITDA	639.51	369.2	303.78	295.63
EBIT	1,467	-673.1	2,248	1,759
EBIT Margin	5.96%	-4.18%	8.09%	6.90%
Effective Tax Rate	9.86%	-	16.04%	-
Advertising Expenses	149.74	188.65	267.8	354.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.